FGF21 and obesity due to melanocortin 4 receptor deficiency: In mice with diet-induced obesity, a single dose of recombinant Fgf21 is sufficient to improve insulin sensitivity and glucose disposal, and chronic administration promotes body weight loss and reduced adiposity (16, 23).